Paper Review Records
全部论文审稿周期
16 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
143
天
Atezolizumab–bevacizumab with or without cisplatin-based HAIC for unresectable HCC: A randomized phase II trial
作者
Yasuto Takeuchi; Masahiko Sue; Nozomi Miyake; Takuya Adachi; Hideki Onishi; Miwa Kawanaka; Akinobu Takaki; Kazuhiro Nouso; Kazuya Kariyama; Tetsuya Yasunaka; Kenji Kuwaki; Junichi Toshimori; Shota Iwado; Akio Moriya; Hiroaki Hagihara; Hiroyuki Takabatake; Masahiro Sakata; Takeshi Hatanaka; Shigeo Shimose; Takumi Kawaguchi; Motoyuki Otsuka展开收起
作者单位
Department of Gastroenterology, Okayama University Hospital, Japan; Department of Gastroenterology, Okayama City Hospital, Japan; Department of Gastroenterology, Fukuyama City Hospital, Japan; Department of Gastroenterology, Okayama Saiseikai General Hospital, Japan; Department of Gastroenterology, Japanese Red Cross Okayama Hospital, Japan; Department of Gastroenterology, Hiroshima City Hospital, Japan; Department of Gastroenterology, Mitoyo General Hospital, Japan; Department of Gastroenterology, Sumitomo Besshi Hospital, Japan; Department of Gastroenterology, Kurashiki Central Hospital, Japan; Department of Gastroenterology, Fukuyama Medical Center, Japan; Department of Gastroenterology, Gunma Saiseikai Maebashi Hospital, Maebashi, Japan; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan展开收起
296
天
Integrative multi-omics identifies cholangiolocarcinoma as a distinct molecular subtype of intrahepatic cholangiocarcinoma
作者
Jun Chen; Xuan Gao; Tianli Chen; Tianyi Dai; Aihua Yang; Xiangnan Xu; Jinhui Kong; Min Zhang; Guoliang Zhang; Ziyao Liu; Siyuan Liu; Yiqiang Chen; Xiaohong Pu; Biao Zhang; Jie Shen; Xinhua Zhu; Jingjing Li展开收起
作者单位
Department of Pathology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, 210008, Jiangsu, China; Department of Biobank, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, 210008, Jiangsu, China; GenePlus-Shenzhen Clinical Laboratory, ShenZhen, 518122, Guangdong, China; Department of Precision Medical Center, Nanjing Normal University Nanjing Drum Tower Hospital, Nanjing, 210008, Jiangsu, China; The Precision Medicine Centre, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, 210008, Jiangsu, China; Geneplus-Beijing, Beijing, 102205, China; Comprehensive Cancer Center, Department of Oncology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, 210008, Jiangsu, China; Division of Hepatobiliary and Transplantation Surgery, Department of General Surgery, Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital, Nanjing, 210008, Jiangsu, China; Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, 210008, Jiangsu, China展开收起
164
天
Targeting circulating fatty acid-binding protein 4 ameliorates obesity-associated hepatic steatosis
作者
Xingshan Jiang; Anthony Avellino; Jianyu Yu; Shanshan Liu; Longgang Zhao; Zhaohua Wang; Xiaochun Han; Himani Thakkar; Jonathan Shilyansky; Zhen Xu; Nicholas Schnicker; Bhagirath Chaurasia; Dustin E. Bosch; Jiaqing Hao; Xuehong Zhang; Sonia L. Sugg; Bing Li展开收起
作者单位
Department of Pathology, University of Iowa, Iowa City, IA, USA; Yale School of Nursing, Yale University, Orange, CT, USA; Department of Internal Medicine-Endocrinology and Metabolism, University of Iowa, Iowa City, IA, USA; Fraternal Order of Eagles Diabetes Research Center, University of Iowa, Iowa City, IA, USA; Protein and Crystallography Facility, University of Iowa, Iowa City, IA, USA; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, USA; Department of Surgery, University of Iowa, Iowa City, IA, USA展开收起
154
天
EQ-5D health utility gains with once-weekly semaglutide 2.4 mg in people with MASH and F2/F3 fibrosis: An analysis of ESSENCE
作者
Margarida Augusto; Robert Bauer; Simon Clancy; Aslak Sindbjerg Poulsen; Fotis Tefos; Michelle Long展开收起
作者单位
Novo Nordisk A/S, Søborg, Denmark; Novo Nordisk Ltd., Gatwick, United Kingdom展开收起
83
天
HBsAg isoforms predict HBsAg seroclearance and finite treatment in patients with chronic hepatitis B after cessation of long-term nucleos(t)ide analogs
作者
Lung-Yi Mak; Mark Anderson; Rex Wan-Hin Hui; Tiffany Fortney; Karen Cheuk-Ying Ho; Rene Geissler; James Fung; Wai-Kay Seto; Gavin Cloherty; Man-Fung Yuen展开收起
作者单位
Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region of China; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong Special Administrative Region of China; Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, UK; Abbott Laboratories, Abbott Diagnostics Division, Abbott Park, IL, USA展开收起
176
天
Serum receptor-interacting protein kinase 3 (RIPK3) is associated with transplant-free survival in acute liver failure
作者
Gautam Mehta; Chengyi Ding; Ugo Soffientini; Jaime L. Speiser; Sarah Bahnassi; Lily Dara; Valerie Durkalski; William M. Lee; Constantine J. Karvellas展开收起
作者单位
Institute for Liver and Digestive Health, University College London, London, UK; Roger Williams Institute of Hepatology, Foundation for Liver Research, London, UK; Department of Biostatistics and Data Science, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA; Department of Medicine, University of Southern California, Los Angeles, CA, USA; Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA; Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA; Divisions of Hepatology and Critical Care Medicine, University of Alberta, Edmonton, Canada展开收起
FAQ
JHEP Reports审稿要多久?
截至2026-11-19,CrushSCI 收录了 JHEP Reports 的 16 篇完整审稿记录。最快一篇从收稿到录用用了 66 天(Corticosteroids in severe alcohol-related hepatitis: A multicenter randomized clinical trial,2026-05-05 收稿,2026-07-10 录用),最慢一篇用了 351 天;平均 169.9 天,中位数 159 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
